of this alkene using HSiMexCl3-x (x ) 1 or 2) is regiospecific.
The pure linear products so obtained react with CH2CH:CH2-
MgBr or LiAlH4 to afford12 1 or 2 directly. These new
reagents satisfy two imperatives for use in further synthe-
sis: (a) they do not contain Si-CPh bonds, which can
undergo facile solvolysis; (b) while metalation or boronation
of the Br-CPh bond is facile, this crucial functionality does
not need to be protected during dendritic carbosilane expan-
sion. Conversion of 1 to the aryl Grignard reagent BrMgC6H4-
(CH2)3SiMe(CH2CH:CH2)2, 3, followed by treatment with
B(OMe)3 then13 HCl yields (HO)2BC6H4(CH2)3SiMe(CH2-
CH:CH2)2, 4, which undergoes palladium-catalyzed (Suzuki)
coupling with further 1 to afford the biphenyl (CH2:CHCH2)2-
MeSi(CH2)3C6H4-C6H4(CH2)3SiMe(CH2CH:CH2)2 (5), or
with 4,4′-diiodobiphenyl to give the corresponding tetra-
phenyl (CH2:CHCH2)2MeSi(CH2)3C6H4-(C6H4)2-C6H4(CH2)3-
SiMe(CH2CH:CH2)2 (6), isolated in 82 and 86% yield,
respectively.
Application of reagents 1 and 2 to modular carbosilane
dendrimer synthesis is illustrated as follows (Scheme 1).
Conversion of 1 to 3 followed by addition of the latter to
Si(CH2CH2CH2SiMe2Cl)4 (7) affords Si(CH2CH2CH2SiMe2-
C6H4CH2CH2CH2SiMe(CH2CH:CH2)2)4 (8), Pt-catalyzed ad-
dition of silane 2 to the simple substrate Si(CH2CH:CH2)4
yields Si(CH2CH2CH2SiMe2CH2CH2CH2C6H4Br)4 (9), while
treatment of the latter with 4/Pd(PPh3)4 gives Si(CH2CH2-
CH2SiMe2CH2CH2CH2C6H4-C6H4CH2CH2CH2SiMe(CH2-
CH:CH2)2)4 (10), all prototypal transformations that use and
generate dendrimer [G-1] analogues in 80% yield or better.
However, 1 can be extended by two reiterative hydrosilyl-
ation cycles to a [G-2] monodendron (11) that can be cleanly
metalated (Mg) and then added to 7, so attaching 4 [G-2]
units to a [G-1] core to yield a product of composition
C252H476Si33, (12), a colorless viscous oil (83%) with M
4433.2. Likewise, boronation of 11 to form its derivative 13
followed by coupling to 9 affords (see Scheme 2) analogue
(11) Hayashi, T.; Konishi, M.; Yokota, K.-I.; Kumada, M. J. Chem. Soc.,
Chem. Commun. 1981, 313.
(12) All compounds have been characterized by multinuclear NMR
spectroscopy (1H, 13C, 29Si), elemental analysis, MALDI-TOF spectrometry
and Gel Permeation Chromatography. Data for selected compounds are as
follows. 1: 1H NMR (CDCl3, δ) 7.38, 7.03 (d, 2H, C6H4), 5.74 (m, 2H,
CH), 4.85 (m, 4H, dCH2), 2.56 (t, 2H, CH2), 1.59 (m, 2H, CH2), 1.53 (d,
4H, CH2), 0.60 (m, 2H, CH2), 0.03 (s, 3H, CH3); 13C{1H} NMR (CDCl3,
δ) 141.4 (C6H4), 134.6 (CH), 131.3, 130.2, 119.4 (C6H4), 113.2 (dCH2),
39.2, 25.6, 21.3, 12.8 (CH2), -5.8 (CH3); 29Si{1H} (CDCl3, δ) 1.02;
MALDI-TOF (m/z, M + Ag+) calcd 431, found 431. Anal. Calcd for C16H23-
BrSi: C, 59.47; H, 7.17. Found: C, 59.95; H, 7.16. 2: 1H NMR (CDCl3,
δ) 7.37, 7.03 (d, 2H, C6H4), 3.84 (m, 1H, SiH), 2.57 (t, 2H, CH2), 1.63,
0.59 (m, 2H, CH2), 0.05 (d, 6H, CH3); 13C{1H} NMR (CDCl3, δ) 141.5,
131.3, 130.3, 119.4 (C6H4), 38.8, 26.3, 13.8 (CH2), -4.5 (CH3); 29Si{1H}
(CDCl3, δ) -13.05. Anal. Calcd for C11H17BrSi: C, 51.36; H, 6.66.
Found: C, 51.82; H, 6.72. 8: 1H NMR (CDCl3, δ) 7.46, 7.18 (d, 8H, C6H4),
5.80 (m, 8H, CH), 4.85 (m, 16H, dCH2), 2.62 (t, 8H, CH2), 1.64 (m, 8H,
CH2), 1.58 (d, 16H, CH2), 1.36 (m, 8H, CH2), 0.70 (m, 8H, CH2), 0.56 (m,
8H, CH2), 0.25 (s, 24H, CH3), -0.05 (s, 12H, CH3); 13C{1H} NMR (CDCl3,
δ) 143.2, 138.6 (C6H4), 134.8 (s, CH), 133.9, 128.3 (C6H4), 113.2 (s, )CH2),
40.0, 25.9, 21.3, 21.2, 18.6, 17.5, 14.3 (CH2), -2.8, -5.8 (CH3); 29Si{1H}
(CDCl3, δ) 1.02 (4 Si), 0.78 (1 Si), -4.16 (4 Si); MALDI-TOF (m/z, M +
Ag+) calcd 1151, found 1151. Anal. Calcd for C84H140Si9: C, 71.92; H,
10.06. Found: C, 72.27; H, 9.88. 9: 1H NMR (CDCl3, δ) 7.40, 7.03 (d,
8H, C6H4), 2.60 (t, 8H, CH2), 1.62 (m, 8H, CH2), 1.40 (m, 8H, CH2), 0.59
(m, 24H, CH2), 0.02 (d, 24H, CH3); 13C NMR (CDCl3, δ) 141.6, 131.3,
130.2, 119.3 (C6H4), 39.3, 26.0, 20.2, 18.6, 17.5, 15.2 (CH2), -3.3 (CH3);
29Si{1H} (CDCl3, δ) 0.60 (1Si), 1.70 (4Si). Anal. Calcd for C56H88Br4Si5:
C, 55.07; H, 7.26. Found: C, 56.30; H, 7.42. 10: 1H NMR (CDCl3, δ)
7.47, 7.20 (d, 16H, C6H4), 5.80 (m, 8H, CH), 4.85 (m, 16H, dCH2), 2.60
(t, 16H, CH2), 1.65 (m, 16H, CH2), 1.58 (d, 16H, CH2), 1.40 (m, 8H, CH2),
0.70 (m, 8H, CH2), 0.60 (m, 24H, CH2), 0.20 (s, 12H, CH3), 0.00 (s, 24H,
CH3); 13C{1H} NMR (CDCl3, δ) 141.6, 141.3, 138.6, 138.5 (C6H4), 134.7
(s, CH), 128.8, 126.8 (C6H4), 113.2 (s, )CH2), 39.7, 39.5, 26.2, 25.8, 21.3,
20.3, 18.6, 17.6, 15.5, 13.0 (s, CH2), -3.2, - 5.8 (s, CH3); 29Si{1H} (CDCl3,
δ) 8.38 (4 Si), 12.09 (5 Si); MALDI-TOF (m/z, M + Ag+) calcd 1983,
found 1985. Anal. Calcd for C120H180Si9: C, 76.85; H, 9.67. Found: C,
76.29; H, 9.59. 11: 1H NMR (CDCl3, δ) 7.38, 7.02 (d, 2H, C6H4), 5.77
(m, 8H, CH), 4.84 (m, 16H, dCH2), 2.55 (t, 2H, CH2), 1.54 (m, 18H, CH2),
1.40 (m, 12H, CH2), 0.75 (m, 26H, CH2), -0.02 (s, 15H, CH3), -0.10 (s,
6H, CH3); 13C{1H} NMR (CDCl3, δ) 141.6 (C6H4), 134.8 (CH), 131.3,
130.2, 119.3 (C6H4), 113.1 (s, dCH2), 39.4 (s, CH2), 26.0, 21.8, 18.9, 18.8,
18.5, 18.3, 17.9, 17.6, 17.4, 13.8 (CH2), -5.0, -5.3, -5.7 (CH3); 29Si{1H}
(CDCl3, δ) 1.85 (1 Si), 1.199 (2 Si), 0.43 (4 Si); MALDI-TOF (m/z, M +
Ag+) calcd 1189, found 1188. Anal. Calcd for C58H107Si7: C, 64.45; H,
9.98. Found: C, 64.06; H, 9.68. 12: 1H NMR (CDCl3, δ) 7.42, 7.18 (d,
8H, C6H4), 5.80 (m, 32H, CH), 4.90 (m, 64H, dCH2), 2.62 (t, 8H, CH2),
1.60 (m, 72H, CH2), 1.35 (d, 64H, CH2), 1.05 (m, 8H, CH2), 0.95 (m, 8H,
CH2), 0.62 (m, 96H, CH2), 0.28 (s, 24H, CH3), 0.10 (s, 24H, CH3), -0.05
(s, 48H, CH3), -0.10 (s, 12 H, CH3); 13C{1H} NMR (CDCl3, δ) 143.2,
138.6 (C6H4), 134.8 (CH), 133.9, 128.3 (C6H4), 113.1 (s, dCH2), 21.5,
18.8-17.5 (CH2), 1.0, -2.8, -5.0, -5.7 (CH3); 29Si{1H} (CDCl3, δ) 1.71
(4 Si), 1.19 (8 Si), 0.88 (1 Si), 0.43 (16 Si), -4.11 (4 Si); MALDI-TOF
(m/z, M + Ag+) calcd 4541, found 4545. Anal. Calcd for C252H476Si33: C,
68.27; H, 10.82. Found: C, 67.44; H, 10.32. 14: 1H NMR (CDCl3, δ)
7.47, 7.20 (d, 16H, C6H4), 5.80 (m, 32H, CH), 4.85 (m, 48H, dCH2), 2.60
(t, 16H, CH2), 1.65 (m, 16H, CH2), 1.58 (d, 64H, CH2), 1.40 (m, 32H,
CH2), 0.60 (m, 134H, CH2), 0.05 (s, 24H, CH3), -0.03 (s, 48H, CH3), -0.06
(s, 12H, CH3), -0.10 (s, 24 H, CH3); 13C{1H} NMR (CDCl3, δ) 141.6,
141.3, 138.6, 138.5 (C6H4), 134.7 (CH), 128.8, 126.8 (C6H4), 113.2 ()CH2),
39.7, 39.5, 26.2, 25.8, 21.3, 20.3, 18.6, 17.6, 15.5, 13.0 (CH2), -3.2, -5.8
(CH3); 29Si{1H} (CDCl3, δ) 1.69 (4 Si), 1. 03 (5 Si), 0.29 (24 Si); MALDI-
Scheme 2
14 of 12, C288H516Si33 (M 4905.9; 57% after chromatographic
purification) which remains fluid at ambient temperature. The
rodlike biphenyl spacers introduced by the aryl-aryl cou-
pling step into the skeletons of 10 and 14 may also be
incorporated directly by using 4,4′-dibromobiphenyl as a
precursor to analogues of reagents 1 and 2, prototypes 8 and
TOF (m/z, M + Ag+) calcd 5014, found 5019. Anal. Calcd for C288H516
Si33: C, 70.51; H, 10.60. Found: C, 70.70; H, 10.45.
-
(13) (a) Miller, R. B.; Dugar, S. Organometallics 1984, 3, 1261. (b)
Miyaura, N.; Suzuki, A. Chem. ReV. 1995, 95, 2457.
Org. Lett., Vol. 2, No. 11, 2000
1551